MARKET

PRAX

PRAX

Praxis Precision Medicines, Inc.
NASDAQ
327.68
+13.12
+4.17%
After Hours: 327.68 0 0.00% 16:44 07/14 EDT
OPEN
318.77
PREV CLOSE
314.56
HIGH
330.17
LOW
313.58
VOLUME
374.56K
TURNOVER
--
52 WEEK HIGH
366.52
52 WEEK LOW
37.19
MARKET CAP
9.14B
P/E (TTM)
-24.5134
1D
5D
1M
3M
1Y
5Y
1D
Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)
TipRanks · 1d ago
Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)
TipRanks · 1d ago
S&P 500 Futures Decline In Premarket Trading; SK Hynix ADR, MKS Lag
Dow Jones · 1d ago
Weekly Report: what happened at PRAX last week (0706-0710)?
Weekly Report · 1d ago
Praxis Precision Med Price Target Announced at $447.00/Share by Goldman Sachs
Dow Jones · 1d ago
Goldman Sachs Initiates Coverage On Praxis Precision Medicine with Buy Rating, Announces Price Target of $447
Benzinga · 1d ago
Praxis Precision initiated with a Buy at Goldman Sachs
TipRanks · 1d ago
RBC Capital Remains a Buy on Praxis Precision Medicines (PRAX)
TipRanks · 3d ago
More
About PRAX
Praxis Precision Medicines, Inc. is an integrated, central nervous system (CNS) precision neuroscience biopharmaceutical company, translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. The Company is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms. Its platform includes Cerebrum, a small-molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, an antisense oligonucleotide platform, is a targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. The Company's product candidates include Ulixacaltamide, Vormatrigine, Relutrigine, PRAX-080, Elsunersen, and others.

Webull offers Praxis Precision Medicines Inc stock information, including NASDAQ: PRAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRAX stock methods without spending real money on the virtual paper trading platform.